Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @NNSANews: Just announced: #NNSA partnership with #healthcare industry results in @US_FDA approval of domestic production of… https://t.co/3SB4RTTHoA
SteveFDA (R-D.C.)
@SGottliebFDA
No Nationwide Shortage: 13 rapid #flu tests available showing acceptable clinical performance https://t.co/mBX1Gkgc6e https://t.co/RCq4PaLJtn
SteveFDA (R-D.C.)
@SGottliebFDA
RT @TomBossert45: Great work! FDA approves new process to conduct life saving medical screenings, bring jobs home, and keep dangerous nucle… QT @NNSANews: Just announced: #NNSA partnership with #healthcare industry results in @US_FDA approval of domestic production of… https://t.co/3SB4RTTHoA)
SteveFDA (R-D.C.)
@SGottliebFDA
HR1892 passes; the brief shutdown will end when POTUS signs this AM; and the professional staff of @US_FDA will be back at their posts today tackling flu, promoting innovation, protecting consumers, and advancing America’s public health https://t.co/91Vhq
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA will be updating our website in the morning; and I’ll communicating directly with our staff in early hours of tomorrow; pending outcome of budget negotiations tonight. We hope for a swift resolution that keeps all our professional staff on the job, p
SteveFDA (R-D.C.)
@SGottliebFDA
This year’s vaccine is effective against the circulating H1N1 and B strains of the #flu; and the spread of H1N1 tends to peak later in the flu season. It’s not too late to get vaccinated https://t.co/SsRJ8cKtWZ QT @CDCDirector: We continue to recommend getting the #flu vaccine to prevent flu. It’s true that flu vaccines often have lower effe… https://t.co/Q5jRnZYLG1)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @NCIDirector: #Precisionmedicine holds incredible promise in improving outcomes for #cancerpatients. Livestream available at… https://t.co/r1tPsAZuPa
SteveFDA (R-D.C.)
@SGottliebFDA
RT @BioCentury: FDA unveils system to facilitate patient meeting requests https://t.co/uLVLwryOOC
SteveFDA (R-D.C.)
@SGottliebFDA
RT @mcipriano93: US FDA Releases Slew Of Guidances On A Fell Day For Complex Generics https://t.co/S2KwWXLMPs
SteveFDA (R-D.C.)
@SGottliebFDA
Recommended 2018 immunization schedule for children and adolescents 18 or younger in the U.S. now available in @CDCMMWR #VaccinesWork https://t.co/e0Fp1eXkB2 https://t.co/oSyIPLQKYo
SteveFDA (R-D.C.)
@SGottliebFDA
With science moving so fast, the pipeline offers many promising opportunities for terminal diseases. We remain committed to safely and effectively advancing these programs; and at the same time giving those facing a terminal illness today a chance to acce
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA committed to working closely w/Congress to advance #RightToTry legislation that gives terminal patients chance to access promising treatments as part of our commitment to promote public health options. We're working closely with legislators; providin
SteveFDA (R-D.C.)
@SGottliebFDA
During my tenure as #FDA Commissioner, I’ve been working closely with stakeholders to advance opportunities to ensure options for those patients diagnosed with terminal illness; including steps to improve our own Expanded Access programs to facilitate acc
SteveFDA (R-D.C.)
@SGottliebFDA
#RightToTry policies rooted in strong desire to help patients facing terminal illnesses access experimental therapies with hope these treatments will help. #FDA shares the administration’s goal to help patients facing terminal diagnosis access promising t
SteveFDA (R-D.C.)
@SGottliebFDA
RT @LauraMclinn: @SGottliebFDA Dr. Gottlieb, Thank you for your shared passion to help terminally ill patients. Sending love from th… https://t.co/SDOvMS4VNF
SteveFDA (R-D.C.)
@SGottliebFDA
At the same time, we're committed to making the development process for breakthrough treatments more efficient and modern, so promising drugs can prove safety and efficacy sooner; and preserving the integrity of policies that make #FDA approval the gold s
SteveFDA (R-D.C.)
@SGottliebFDA
Read more about some of the steps we've taken to improve our Expanded Access programs here: https://t.co/pKtMy7rTYh … We'll be announcing some new steps in coming months as we make sure our programs work to help patients who face terminal disease get acce
SteveFDA (R-D.C.)
@SGottliebFDA
You can read more about some of the steps we've taken to improve our Expanded Access programs: https://t.co/pKtMy7rTYh We'll be announcing some new steps in coming months as we make sure our programs work to help patients who face terminal disease get acc
SteveFDA (R-D.C.)
@SGottliebFDA
RT @DonnaYoungDC: #RightToTry #compassionateuse #FDA #pharma #biotech https://t.co/ihO5IHaH3W QT @SGottliebFDA: Read more about some of the steps we've taken to improve our Expanded Access programs here: https://t.co/pKtMy7rTYh… https://t.co/UQdx5lRMZI)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAcdrhIndustry: #DidYouKnow https://t.co/dM65sc44Em QT @SGottliebFDA: Helpful tips from @CDCgov - Most people with #flu have mild illness and don’t need medical care. However, stay aler… https://t.co/3ZG6nQ9RDm)